<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Traumatology and Orthopedics of Russia</journal-id><journal-title-group><journal-title xml:lang="en">Traumatology and Orthopedics of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Травматология и ортопедия России</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2311-2905</issn><issn publication-format="electronic">2542-0933</issn><publisher><publisher-name xml:lang="en">Vreden National Medical Research Center of Traumatology and Orthopedics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17578</article-id><article-id pub-id-type="doi">10.17816/2311-2905-17578</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>Clinical studies</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">The potential utility of synovial C-reactive protein, interleukin-6, and presepsin in diagnostics of periprosthetic joint infection</article-title><trans-title-group xml:lang="ru"><trans-title>Возможность использования синовиальных С-реактивного белка, интерлейкина-6 и пресепсина в диагностике перипротезной инфекции</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5750-4459</contrib-id><name-alternatives><name xml:lang="en"><surname>Lyubimova</surname><given-names>Lyudmila V.</given-names></name><name xml:lang="ru"><surname>Любимова</surname><given-names>Людмила Валентиновна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>borisova-80@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9976-7866</contrib-id><name-alternatives><name xml:lang="en"><surname>Pavlova</surname><given-names>Svetlana I.</given-names></name><name xml:lang="ru"><surname>Павлова</surname><given-names>Светлана Ивановна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>flavonoid@yandex.ru</email><xref ref-type="aff" rid="aff2"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-1560-470X</contrib-id><name-alternatives><name xml:lang="en"><surname>Nikolaev</surname><given-names>Nikolay S.</given-names></name><name xml:lang="ru"><surname>Николаев</surname><given-names>Николай Станиславович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.), Professor</p></bio><bio xml:lang="ru"><p>д-р мед. наук, профессор</p></bio><email>nikolaev@orthoscheb.ru</email><xref ref-type="aff" rid="aff1"/><xref ref-type="aff" rid="aff4"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5262-0197</contrib-id><name-alternatives><name xml:lang="en"><surname>Lyubimov</surname><given-names>Evgeniy A.</given-names></name><name xml:lang="ru"><surname>Любимов</surname><given-names>Евгений Александрович</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>elyubimov@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9507-9118</contrib-id><name-alternatives><name xml:lang="en"><surname>Pchelova</surname><given-names>Nadezhda N.</given-names></name><name xml:lang="ru"><surname>Пчелова</surname><given-names>Надежда Николаевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>nadyapchelova@mail.ru</email><xref ref-type="aff" rid="aff3"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-1720-1741</contrib-id><name-alternatives><name xml:lang="en"><surname>Emelianov</surname><given-names>Vladimir Y.</given-names></name><name xml:lang="ru"><surname>Емельянов</surname><given-names>Владимир Юрьевич</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>vemelianov@mail.ru</email><xref ref-type="aff" rid="aff3"/><xref ref-type="aff" rid="aff4"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Federal Center of Traumatology, Orthopedics and Arthroplasty (Cheboksary)</institution></aff><aff><institution xml:lang="ru">ФГБУ «Федеральный центр травматологии, ортопедии и эндопротезирования» Минздрава России (г. Чебоксары)</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><aff-alternatives id="aff2"><aff><institution xml:lang="en">Chuvash State University named after I.N. Ulyanov</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Чувашский государственный университет им. И.Н. Ульянова»</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><aff-alternatives id="aff3"><aff><institution xml:lang="en">Federal Center of Traumatology, Orthopedics and Arthroplasty (Cheboksary)</institution></aff><aff><institution xml:lang="ru">ФГБУ «Федеральный центр травматологии, ортопедии и эндопротезирования» Минздрава России (г. Чебоксары)</institution></aff></aff-alternatives><aff-alternatives id="aff4"><aff><institution xml:lang="en">Chuvash State University named after I.N. Ulyanov</institution></aff><aff><institution xml:lang="ru">ФГБОУ ВО «Чувашский государственный университет им. И.Н. Ульянова»</institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2024-11-05" publication-format="electronic"><day>05</day><month>11</month><year>2024</year></pub-date><pub-date date-type="pub" iso-8601-date="2024-12-18" publication-format="electronic"><day>18</day><month>12</month><year>2024</year></pub-date><volume>30</volume><issue>4</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>5</fpage><lpage>13</lpage><history><date date-type="received" iso-8601-date="2024-07-08"><day>08</day><month>07</month><year>2024</year></date><date date-type="accepted" iso-8601-date="2024-08-06"><day>06</day><month>08</month><year>2024</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2024, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2024, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2024,</copyright-statement><copyright-year>2024</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journal.rniito.org/jour/article/view/17578">https://journal.rniito.org/jour/article/view/17578</self-uri><abstract xml:lang="en"><p><bold>Background<italic>. </italic></bold>Diagnostics of infectious complications in joint replacement surgery remains a significant challenge, particularly when microbiological analysis of biological material fails to reveal pathogen growth.</p> <p><bold>The aim of the study<italic> </italic></bold>was to determine threshold values for C-reactive protein, interleukin-6, and presepsin levels, and to assess their diagnostic value in detecting periprosthetic joint infection.</p> <p><bold>Methods<italic>.</italic></bold> A prospective cohort single-center blinded study was conducted involving cases of revision arthroplasty for periprosthetic joint infection (PJI) and aseptic prosthetic loosening. The study included 66 patients divided into two groups: Group I (n = 17), with confirmed PJI using the 2018 ICM criteria, and Group II (n = 49), with aseptic prosthetic loosening. Synovial fluid samples were subjected to bacteriological and cytological analysis, measuring levels of C-reactive protein (CRP), presepsin, and interleukin-6 (IL-6). ROC analysis, sensitivity, specificity, accuracy, and threshold values were determined for laboratory data.</p> <p><bold>Results<italic>. </italic></bold>The highest diagnostic accuracy in distinguishing between PJI and aseptic loosening was observed in the leukocyte count in synovial fluid (AUC 0.928; 95% CI: 0.837-0.977, p&lt;0.0001). Elevated synovial CRP levels were associated with infection, with an AUC of 0.776 (95% CI: 0.656-0.870, p = 0.0004), and IL-6 had an AUC of 0.712 (95% CI: 0.583-0.820; p = 0.0048). Presepsin levels, however, showed no significant difference between groups (AUC 0.582; 95% CI: 0.453-0.703; p = 0.3344). Threshold values were set at 5.6 mg/l for CRP, 1212.0 pg/ml for presepsin, and 988.5 pg/ml for IL-6. Sensitivity, specificity, and accuracy for PJI diagnosis were determined for CRP at 62.5%, 85.7%, and 80.0%; for IL-6 at 87.5%, 63.0%, and 69.4%; and for presepsin at 43.8%, 79.6%, and 70.8%, respectively.</p> <p><bold>Conclusion<italic>. </italic></bold>In cases where synovial leukocyte counts are at borderline levels, the additional assessment of synovial fluid cellular composition and simple, cost-effective markers such as synovial CRP and IL-6 may be recommended to confirm PJI.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность<italic>.</italic></bold> Диагностика инфекционных осложнений при протезировании суставов остается актуальной задачей, особенно в случаях отсутствия роста возбудителей при микробиологическом исследовании биоматериала.</p> <p><bold>Целью исследования</bold> стало определение пороговых значений уровня С-реактивного белка, интерлейкина-6 и пресепсина и их диагностической значимости для выявления перипротезной инфекции.</p> <p><bold>Материал и методы<italic>.</italic></bold> Проведено проспективное когортное одноцентровое слепое исследование случаев ревизионной артропластики крупных суставов по поводу перипротезной инфекции (ППИ) и асептической нестабильности эндопротеза. В исследование вошли 66 пациентов, которые были разделены на группы: группа I (<italic>n</italic> = 17) — случаи подтвержденной ППИ согласно критериям ICM (2018), группа II (<italic>n</italic> = 49) — случаи асептической нестабильности эндопротеза. Были выполнены бактериологическое и цитологическое исследования образцов синовиальной жидкости с определением уровней С-реактивного белка (СРБ), пресепсина и интерлейкина-6 (ИЛ-6). Для лабораторных данных проводился ROC-анализ, определение чувствительности, специфичности, точности и пороговых значений.</p> <p><bold>Результаты<italic>.</italic></bold> Наибольшей достоверностью для диагностики ППИ и асептической нестабильности эндопротеза обладали показатели количества лейкоцитов в синовиальной жидкости (AUC 0,928; ДИ 95%: 0,837–0,977, <italic>p</italic>&lt;0,0001). При инфекции также имелось повышение синовиального СРБ с AUC 0,776 (ДИ 95%: 0,656–0,870, <italic>p</italic> = 0,0004) и ИЛ-6 с AUC 0,712 (ДИ 95%: 0,583–0,820; <italic>p</italic> = 0,0048). В то же время уровень пресепсина не различался между группами (AUC 0,582; ДИ 95%: 0,453–0,703; <italic>p</italic> = 0,3344). Пороговые значения составили для СРБ 5,6 мг/л, пресепсина — 1212,0 пг/мл, интерлейкина-6 — 988,5 пг/мл. Чувствительность, специфичность и точность для диагностики ППИ определены для СРБ на уровне 62,5%, 85,7% и 80,0%; для интерлейкина-6 — 87,5%, 63,0% и 69,4%; для пресепсина 43,8%, 79,6% и 70,8% соответственно.</p> <p><bold>Заключение<italic>. </italic></bold>При пограничных значениях уровня синовиальных лейкоцитов для подтверждения ППИ в дополнение к оценке клеточного состава синовиальной жидкости можно рекомендовать использование таких простых и недорогих исследований, как определение уровня синовиальных СРБ и ИЛ-6.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>periprosthetic joint infection</kwd><kwd>aseptic prosthetic loosening</kwd><kwd>revision arthroplasty</kwd><kwd>synovial markers</kwd><kwd>C-reactive protein</kwd><kwd>interleukin-6</kwd><kwd>presepsin</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>перипротезная инфекция</kwd><kwd>асептическая нестабильность эндопротеза</kwd><kwd>ревизионное эндопротезирование</kwd><kwd>синовиальные маркеры</kwd><kwd>С-реактивный белок</kwd><kwd>интерлейкин-6</kwd><kwd>пресепсин</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Gehrke T., Alijanipour P., Parvizi J. The management of an infected total knee arthroplasty. Bone Joint J. 2015;97-B(10 Suppl A):20-29. doi: 10.1302/0301-620X.97B10.36475.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Tsang S.T.J., Gwynne P.J., Gallagher M.P., Simpson A.H.R.W. The biofilm eradication activity of acetic acid in the management of periprosthetic joint infection. Bone Joint Res. 2018;7(8):517-523. doi: 10.1302/2046-3758.78.BJR-2018-0045.R1.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Romanò C.L., Khawashki H.A., Benzakour T., Bozhkova S., Del Sel H., Hafez M. et al. The W.A.I.O.T. Definition of High-Grade and Low-Grade Peri-Prosthetic Joint Infection. J Clin Med. 2019;8(5):650. doi: 10.3390/jcm8050650.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Parvizi J., Tan T.L., Goswami K., Higuera C., Della Valle C., Chen A.F. et al. The 2018 Definition of Periprosthetic Hip and Knee Infection: An Evidence-Based and Validated Criteria. J Arthroplasty. 2018;33(5): 1309-1314.e2. doi: 10.1016/j.arth.2018.02.078.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Della Valle C., Parvizi J., Bauer T.W., DiCesare P.E., Evans R.P., Segreti J. et al. American Academy of Orthopaedic Surgeons clinical practice guideline on: the diagnosis of periprosthetic joint infections of the hip and knee. J Bone Joint Surg Am. 2011;93(14):1355-1357. doi: 10.2106/JBJS.9314ebo.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>McNally M., Sousa R., Wouthuyzen-Bakker M., Chen A.F., Soriano A., Vogely H.C. et al. The EBJIS definition of periprosthetic joint infection. Bone Joint J. 2021;103-B(1):18-25. doi: 10.1302/0301-620X.103B1.BJJ-2020-1381.R1.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Любимова Л.В., Божкова С.А., Пчелова Н.Н., Преображенская Е.В., Любимов Е.А. Роль культуронегативной инфекции в структуре инфекционных осложнений после эндопротезирования коленных суставов. Гений ортопедии. 2023;29(4):402-409. doi: 10.18019/1028-4427-2023-29-4-402-409. Lyubimova L.V., Bozhkova S.A., Pchelova N.N., Preobrazhenskaya E.V., Lyubimov E.A. The role of culture-negative infection among infectious complications after total knee arthroplasty. Genij Ortopedii. 2023;29(4):402-409. (In Russian). doi: 10.18019/1028-4427-2023-29-4-402-409.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Fernandez-Sampedro M., Salas-Venero C., Fariñas-Álvarez C., Sumillera M., Pérez-Carro L., Fakkas-Fernandez M. et al. 26 Postoperative diagnosis and outcome in patients with revision arthroplasty for aseptic loosening. BMC Infect Dis. 2015;15:232. doi: 10.1186/s12879-015-0976-y.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Osmon D.R., Berbari E.F., Berendt A.R., Lew D., Zimmerli W., Steckelberg J.M. et al. Diagnosis and management of prosthetic joint infection: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis. 2013;56(1):e1-e25. doi: 10.1093/cid/cis803.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Пантелеев А.Н., Божкова С.А., Тихилов Р.М., Каземирский А.В., Анисимова Л.О., Гузюкина С.А. и др. Экстренное гистологическое исследование в диагностике перипротезной инфекции при ревизионном эндопротезировании коленного сустава. Гений ортопедии. 2023;29(2):180-189. doi: 10.18019/1028-4427-2023-29-2-180-189. Panteleev A.N., Bozhkova S.A., Tikhilov R.M., Kazemirsky A.V., Anisimova L.O., Guzyukina S.A. et al. Emergency histological examination in diagnosis of periprosthetic joint infection in revision total knee arthroplasty. Genij Ortopedii. 2023;29(2):180-189. (In Russian). doi: 10.18019/1028-4427-2023-29-2-180-189.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Marazzi M.G., Randelli F., Brioschi M., Drago L., Romanò C.L., Banfi G. et al. Presepsin: A potential biomarker of PJI? A comparative analysis with known and new infection biomarkers. Int J Immunopathol Pharmacol. 2018;31:394632017749356. doi: 10.1177/0394632017749356.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Saleh A., Ramanathan D., Siqueira M.B.P., Klika A.K., Barsoum W.K., Rueda C.A.H. The Diagnostic Utility of Synovial Fluid Markers in Periprosthetic Joint Infection: A Systematic Review and Meta-analysis. J Am Acad Orthop Surg. 2017;25(11):763-772. doi: 10.5435/JAAOS-D-16-00548.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Lee Y.S., Koo K.H., Kim H.J., Tian S., Kim T.Y., Maltenfort M.G. et al. Synovial Fluid Biomarkers for the Diagnosis of Periprosthetic Joint Infection: A Systematic Review and Meta-Analysis. J Bone Joint Surg Am. 2017;99(24):2077-2084. doi: 10.2106/JBJS.17.00123.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Николаев Н.С., Пчелова Н.Н., Преображенская Е.В., Назарова В.В., Добровольская Н.Ю. «Неожиданные» инфекции при асептических ревизиях. Травматология и ортопедия России. 2021;27(3):56-70. doi: 10.21823/2311-2905-2021-27-3-56-70. Nikolaev N.S., Pchelova N.N., Preobrazhenskaya E.V., Nazarova V.V., Dobrovol’skaya N.Y. “Unexpected” Infections in Revision Arthroplasty for Aseptic Loosening. Traumatology and Orthopedics of Russia. 2021;27(3):56-70. (In Russian). doi: 10.21823/2311-2905-2021-27-3-56-70.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Qin L., Li X., Wang J., Gong X., Hu N., Huang W. Improved diagnosis of chronic hip and knee prosthetic joint infection using combined serum and synovial IL-6 tests. Bone Joint Res. 2020;9(9):587-592. doi: 10.1302/2046-3758.99.BJR-2020-0095.R1.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Delva M.L., Samuel L.T., Acuña A.J., Kamath A.F. Presepsin as a diagnostic biomarker of peri-prosthetic joint infection: a review of the literature. Eur J Orthop Surg Traumatol. 2023;33(4):695-700. doi: 10.1007/s00590-022-03232-z.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Busch A., Jäger M., Engler H., Wasssenaar D., Bielefeld C., Wegner A. Diagnostic Accuracy of Synovial Neopterin, TNF-α and Presepsin in Periprosthetic Joint Infection: A Prospective Study. Z Orthop Unfall. 2022;160(3): 299-306. (In English). doi: 10.1055/a-1303-5105.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Miamidian J.L., Toler K., McLaren A., Deirmengian C. Synovial Fluid C-reactive Protein Clinical Decision Limit and Diagnostic Accuracy for Periprosthetic Joint Infection. Cureus. 2024;16(1):e52749. doi: 10.7759/cureus.52749.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Diniz S.E., Ribau A., Vinha A., Oliveira J.C., Abreu M.A., Sousa R. Simple and inexpensive synovial fluid biomarkers for the diagnosis of prosthetic joint infection according to the new EBJIS definition. J Bone Jt Infect. 2023;8(2):109-118. doi: 10.5194/jbji-8-109-2023.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Ottink K.D., Strahm C., Muller-Kobold A., Sendi P., Wouthuyzen-Bakker M. Factors to Consider When Assessing the Diagnostic Accuracy of Synovial Leukocyte Count in Periprosthetic Joint Infection. J Bone Jt Infect. 2019;4(4):167-173. doi: 10.7150/jbji.34854.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Zahar A., Lausmann C., Cavalheiro C., Dhamangaonkar A.C., Bonanzinga T., Gehrke T. et al. How Reliable Is the Cell Count Analysis in the Diagnosis of Prosthetic Joint Infection? J Arthroplasty. 2018;33(10):3257-3262. doi: 10.1016/j.arth.2018.05.018.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Sousa R., Serrano P., Gomes Dias J., Oliveira J.C., Oliveira A. Improving the accuracy of synovial fluid analysis in the diagnosis of prosthetic joint infection with simple and inexpensive biomarkers: C-reactive protein and adenosine deaminase. Bone Joint J. 2017;99-B(3):351-357. doi: 10.1302/0301-620X.99B3.BJJ-2016-0684.R1.</mixed-citation></ref></ref-list></back></article>
